| 12351581 |
Compounds for FGFR inhibition |
Jay Bradford Fell, John E. Robinson, John P. Fischer, Logan E. Vine, Martha E. Rodriguez +9 more |
2025-07-08 |
|
| 12281122 |
PI3K inhibitors |
Payal Chatterjee, Mark Joseph Chicarelli, Michael L. Conner, John P. Fischer, Jennifer Fulton +14 more |
2025-04-22 |
|
| 12187727 |
Methods for antagonizing a melanocortin 4 receptor |
Christopher Ryan Butler, Michelle Renee Garnsey, Kevin Alexander Ogilvie, Jana Polivkova, Matthew Forrest Sammons +1 more |
2025-01-07 |
|
| 11643412 |
Melanocortin 4 receptor antagonists and uses thereof |
Christopher Ryan Butler, Michelle Renee Garnsey, Kevin Alexander Ogilvie, Jana Polivkova, Matthew Forrest Sammons +1 more |
2023-05-09 |
$1,158,824,000 |
| 11634410 |
Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors |
Matthew S. Dowling, Dilinie Fernando, Kentaro Futatsugi, Kim Huard, Thomas Victor Magee +5 more |
2023-04-25 |
$397,929,000 |
| 10988463 |
Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors |
Matthew S. Dowling, Dilinie Fernando, Kentaro Futatsugi, Kim Huard, Thomas Victor Magee +5 more |
2021-04-27 |
$1,331,995,000 |
| 10787438 |
Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors |
Matthew S. Dowling, Dilinie Fernando, Kentaro Futatsugi, Kim Huard, Thomas Victor Magee +5 more |
2020-09-29 |
$414,122,000 |
| 10174007 |
Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors |
Matthew S. Dowling, Dilinie Fernando, Kentaro Futatsugi, Kim Huard, Thomas Victor Magee +5 more |
2019-01-08 |
$262,548,000 |
| 9809579 |
Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors |
Matthew S. Dowling, Dilinie Fernando, Kentaro Futatsugi, Kim Huard, Thomas Victor Magee +5 more |
2017-11-07 |
$741,555,000 |
| 9394285 |
Indole and indazole compounds that activate AMPK |
Samit Kumar Bhattacharya, Kimberly O. Cameron, Matthew S. Dowling, David Christopher Ebner, David James Edmonds +5 more |
2016-07-19 |
$914,444,000 |
| 9181252 |
N1/N2-lactam acetyl-CoA carboxylase inhibitors |
David A. Griffith, Robert L. Dow, Scott W. Bagley |
2015-11-10 |
$341,611,000 |
| 8993586 |
N1/N2-lactam acetyl-CoA carboxylase inhibitors |
David A. Griffith, Robert L. Dow, Scott W. Bagley |
2015-03-31 |
$327,329,000 |
| 8889730 |
Indole and indazole compounds that activate AMPK |
Samit Kumar Bhattacharya, Kimberly O. Cameron, Matthew S. Dowling, Dilinie Fernando, David Christopher Ebner +4 more |
2014-11-18 |
$598,283,000 |
| 8859773 |
N1/N2-lactam acetyl-CoA carboxylase inhibitors |
David A. Griffith, Robert L. Dow, Scott W. Bagley |
2014-10-14 |
$166,604,000 |
| 7858631 |
Substituted pyrido [2,3-d] pyrimidinone compounds |
Rustum Boyce, Natalia Aurrecoechea, Daniel Chu, Bryan Chang |
2010-12-28 |
$6,011,000 |
| 7858641 |
Substituted dihydroisoquinolinone compounds |
Rustum Boyce, Natalia Aurrecoechea, Daniel Chu, Bryan Chang |
2010-12-28 |
$6,011,000 |
| 7625909 |
Substituted quinazolinone compounds |
Rustum Boyce, Natalia Aurrecoechea, Daniel Chu, Christopher R. CONLEE, Brian D. Thompson +9 more |
2009-12-01 |
$20,169,000 |
| 7034033 |
Substituted quinazolinone compounds |
Rustum Boyce, Natalia Aurrecoechea, Daniel Chu, Bryan Chang |
2006-04-25 |
|
